Your biosimilar, your journey, Sponsored Content by Cytiva
For biosimilar developers, stars are now within reach. With blockbuster drug patents for more than $200 billion in annual revenue set to expire by 2030 (1), there’s a world of opportunities on the horizon. To be successful, developers must carefully consider their market strategy and manufacturing goals.
Are you ready for lift off?
All systems go: Complete your pre-launch checklist
Target the right biosimilar It is important to weigh your timing, target market, and team’s expertise, including regulatory, against what patents are expiring.
Choose the best path forward
Implementing the setup that is right for your needs—single-use or stainless steel, permanent or modular—will offer the best return on your investment.
Map out ideal timeline
Whether you want to be first, second, or third to market, timing matters. Your market entry point will impact late-stage production and regulatory decisions.
